Hansoh Pharmaceutical (03692.HK): All approved indications of its marketed innovative drugs have been included in the medical insurance catalog.

Zhitong Finance APP News, Hansoh Pharmaceutical (03692.HK) announced that the Group's innovative drug Ameile has successfully been included in the new edition of the "National Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance Drug Catalog (2026)" with one additional indication, and Xinyue with two additional indications. The new edition of the national catalog will be officially implemented on January 1, 2027.